Enhertu Becomes First HER2 Tumour-Agnostic Therapy Approved in Europe for solid tumours
AstraZeneca and Daiichi Sankyo announced that the European Commission has approved Enhertu (trastuzumab deruxtecan) as a monotherapy for adult patients with unresectable or metastatic HER2-positive (IHC 3+) solid tumours...
Alembic’s New Gujarat Hub to Speed Up Medicine Supply
Alembic Pharmaceuticals Limited has marked a significant step forward in its logistics infrastructure with the launch of a new Central Stock Point (CSP) in Kheda,...
Union Health Minister Reviews Dengue Preparedness in Delhi
Union Health and Family Welfare Minister Shri J.P. Nadda convened a high-level meeting on July 1, 2026, to evaluate Delhi's readiness for the dengue season. Officials...
Have Your Say Before It’s Law: Health Ministry Invites Public Feedback on Pharmacy Bill
The Ministry of Health and Family Welfare has released an updated version of its proposed National Pharmacy Commission Bill, marking the next step in...
Mankind Pharma Announces Strategic Collaboration with Denovo Sciences to Advance AI-Driven Drug Discovery
Mankind Pharma Ltd, one of India’s leading pharmaceutical companies, announced a strategic collaboration with Denovo Sciences, a pioneer in artificial intelligence-driven therapeutics. This partnership...
Alembic Pharmaceuticals receives final USFDA approval for Dapsone Gel, 5%for topical treatment of acne vulgaris
Alembic Pharmaceuticals Limited has secured final regulatory clearance from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for...